The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S. drug ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

A series of case reports to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD), ...

Eli Lilly's efsitora alfa was noninferior to once-daily insulin in type 2 diabetes, but an increased hypoglycemia risk was seen in type 1 diabetes.

Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical ...

Insulin resistance is associated with 31 different diseases and, in women, is also linked to higher odds of an early death, a ...

Research shows elevated metformin in diabetic foot ulcer exudates when combined with insulin, highlighting potential for ...

A fusion protein, efsitora alfa combines a single-chain variant of insulin with a human IgG2 Fc domain, designed for once-weekly subcutaneous administration. Its low peak-to-trough ratio may ...

The Type 1 Diabetes Grand Challenge has awarded £2.7 million (about $3.6 million) to six different projects aimed at developing novel insulins to treat patients with type 1 diabetes. The universities ...